<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31226" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin E</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Medina</surname>
            <given-names>Jacquelyn</given-names>
          </name>
          <aff>Orange Park Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacquelyn Medina declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31226.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Vitamin E or tocopherol is a fat-soluble vitamin that functions as an antioxidant, protecting the cell membrane. As with all vitamins, the body does not form vitamin E. It solely forms from the photosynthetic processes of plants and therefore must be consumed from outside sources in small quantities. Vitamin E is a medication used to manage and treat vitamin E deficiency states and disease prevention. This activity outlines the indications, action, adverse reactions, contraindications, and other key elements of vitamin E therapy in the clinical setting as relates to the essential points needed by members of an interprofessional team managing the care of patients with vitamin E deficiency and applications of vitamin E in disease prevention.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action of vitamin E.</p></list-item><list-item><p>Describe the potential adverse effects of vitamin E.</p></list-item><list-item><p>Review the appropriate monitoring when patients are taking vitamin E.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance vitamin E treatment and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31226&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31226">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31226.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Vitamin E or tocopherol is a fat-soluble vitamin that functions as an antioxidant, protecting the cell membrane. As with all vitamins, the body does not form vitamin E. It solely forms from the photosynthetic processes of plants and therefore must be consumed from outside sources in small quantities. It is found abundantly in olive and sunflower oils, as well as nuts, soybeans, avocados, wheat, and green leafy vegetables.<xref ref-type="bibr" rid="article-31226.r1">[1]</xref></p>
        <p>Vitamin E encompasses eight forms, including alpha, beta, gamma, and delta-tocopherol and alpha, beta, gamma, and delta-tocotrienol. However, only alpha-tocopherol is found in abundance and maintained well in human plasma.<xref ref-type="bibr" rid="article-31226.r2">[2]</xref><xref ref-type="bibr" rid="article-31226.r3">[3]</xref>&#x000a0;Vitamin E supplements usually contain all isomers of alpha-tocopherol and have about half the activity level of natural sources. While other forms of tocopherols exist, only the alpha form or equivalents are measured for standard dietary sufficiency.</p>
        <p>As with all fat-soluble vitamins, transport and absorption require intact fat digestion mechanisms. Fat metabolism involves both lingual and gastric lipases, bile salts, pancreatic enzymes, and intestinal absorption. Pancreatic enzymes break down tocopheryl-ester bonds.<xref ref-type="bibr" rid="article-31226.r4">[4]</xref>&#x000a0;Chylomicrons then transport alpha-tocopherol through the lymphatics to the liver. Once broken down in the liver, tocopherol is released from the chylomicrons. Alpha-tocopherol transfer protein is selective for alpha-tocopherol over other vitamin E forms and helps package the molecule with low-density lipoprotein, which is subsequently secreted into the bloodstream.<xref ref-type="bibr" rid="article-31226.r4">[4]</xref></p>
        <p>Of the fat-soluble vitamins, deficiency of vitamin E is uncommon. Disorders leading to disruption of fat metabolism are the usual causes of deficiency.<xref ref-type="bibr" rid="article-31226.r5">[5]</xref><xref ref-type="bibr" rid="article-31226.r6">[6]</xref><xref ref-type="bibr" rid="article-31226.r7">[7]</xref>&#x000a0;Cystic fibrosis or chronic pancreatitis can lead to pancreatic enzyme insufficiency. Disorders such as primary biliary cholangitis, primary sclerosing cholangitis, or decompensated cirrhosis will lead to cholestasis. This condition, in turn, will lead to an insufficient amount of bile necessary for normal fat absorption. Long-standing, severe cholestasis will eventually lead to low levels of vitamin E.<xref ref-type="bibr" rid="article-31226.r6">[6]</xref><xref ref-type="bibr" rid="article-31226.r7">[7]</xref>&#x000a0;Resection of the bowel or disease of the small intestine can also cause deficiency due to decreased absorption of vitamin E. Bile acids are absorbed in the terminal ileum, and therefore, Crohn disease or amyloid infiltration will reduce the pool of bile acids and hence decrease fat absorption.<xref ref-type="bibr" rid="article-31226.r6">[6]</xref><xref ref-type="bibr" rid="article-31226.r7">[7]</xref></p>
        <p>Ataxia with vitamin E deficiency (AVED) is a genetic disease caused by a mutation in the alpha-tocopherol transport protein, TTPA.<xref ref-type="bibr" rid="article-31226.r8">[8]</xref><xref ref-type="bibr" rid="article-31226.r9">[9]</xref>&#x000a0;AVED usually manifests in the pre-teen to teenage years and clinically manifests with ataxia, dysarthria, decreased proprioception, vibratory sensation, and decreased reflexes due to the neurologic dysfunction linked to vitamin E deficiency, despite normal intake of the vitamin. A mutation of microsomal triglyceride transfer protein will lead to abetalipoproteinemia. In this disorder, there are absent or very low levels of low-density lipoproteins and, consequently, low levels of vitamin E transport, as well as other fat-soluble vitamins.<xref ref-type="bibr" rid="article-31226.r10">[10]</xref>&#x000a0;Vitamin E deficiency can clinically manifest with neuromuscular disruption. Neuropathy has variable involvement in the peripheral nervous system, causing gait disturbance and loss of proprioceptive and vibratory sense.<xref ref-type="bibr" rid="article-31226.r8">[8]</xref><xref ref-type="bibr" rid="article-31226.r11">[11]</xref>&#x000a0;Red blood cell lifespan is shortened in chronic vitamin E deficient patients, clinically presenting with hemolysis.<xref ref-type="bibr" rid="article-31226.r5">[5]</xref></p>
        <p>The use of alpha-tocopherol as a preventative antioxidant has been studied concerning cardiovascular disease, cancer, age-related macular degeneration, nonalcoholic fatty liver disease, and Alzheimer disease. The theory is that lipid oxidation plays a pivotal role in developing cardiovascular disease and that the use of antioxidants as adjunctive therapy is useful for prevention. However, studies of vitamin E in the prevention of cardiovascular disease have not proven beneficial, with inconsistent outcomes and inherent study limitations.<xref ref-type="bibr" rid="article-31226.r12">[12]</xref><xref ref-type="bibr" rid="article-31226.r13">[13]</xref></p>
        <p>Antioxidant use of vitamin E in the prevention of cancers has also not been shown to be effective and may increase the risk of prostate cancer. In the SELECT trial, researchers studied selenium and vitamin E to see what role there was for supplementation in decreasing the incidence of prostate cancer. Participants were randomly assigned to either supplementation with selenium, vitamin E, both, or placebo. The study resulted in an increase in incidence in those in the vitamin E-only group. Other trials on the role of vitamin E and prostate cancer showed conflicting results.<xref ref-type="bibr" rid="article-31226.r4">[4]</xref><xref ref-type="bibr" rid="article-31226.r13">[13]</xref><xref ref-type="bibr" rid="article-31226.r14">[14]</xref></p>
        <p>The progression of nonalcoholic fatty liver disease has been shown to be decreased by high-dose supplementation of alpha-tocopherol.<xref ref-type="bibr" rid="article-31226.r15">[15]</xref>&#x000a0;Long-term studies remain necessary to show continued benefits. With age-related macular degeneration, a combination of antioxidants as an adjunctive therapy has shown to slow progression but has not proven to prevent development. Additionally, high-dose vitamin E correlates with an increased progression of retinitis pigmentosa.<xref ref-type="bibr" rid="article-31226.r16">[16]</xref><xref ref-type="bibr" rid="article-31226.r17">[17]</xref>&#x000a0;Alpha-tocopherol high dose supplements may also play a role in slowing the progression of Alzheimer disease.<xref ref-type="bibr" rid="article-31226.r18">[18]</xref></p>
      </sec>
      <sec id="article-31226.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>The primary mechanism of action of alpha-tocopherol is as a scavenger of free radicals. It binds to free radicals, protecting cellular components from oxidative damage. Peroxidation of polyunsaturated fatty acids in the cell membrane from free radicals leads to cellular injury. Vitamin E plays a protective role. It also inhibits the aggregation of platelets, monocyte adhesion, and proliferation of cells.<xref ref-type="bibr" rid="article-31226.r1">[1]</xref><xref ref-type="bibr" rid="article-31226.r4">[4]</xref></p>
        <p>Vitamin E is hepatically metabolized&#x000a0;and is primarily excreted in the bile and feces but also the urine. It is also stored in the body's adipose tissues.</p>
      </sec>
      <sec id="article-31226.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Vitamin E is available in capsules&#x000a0;of 100, 200, 400, 600, and 1000 international units. Tablet dose forms are 100 and 200 units. A solution formulation has 1150 units per 1.25 mL, 400 units&#x000a0;per mL, and 15 units per 0.3 mL.</p>
        <p>Routine supplementation of vitamin E is not recommended for non-deficient children or adults. If a deficiency is detected or a person suffers from a disorder leading to absent or low levels of vitamin E, oral supplementation is available over the counter.</p>
        <p>Adult dosing:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vitamin E deficiency: take 60 to 75 units by mouth daily.
<list list-type="bullet"><list-item><p>The maximum dose is 1000 units daily. Cystic fibrosis patients should get 100 to 400 units per day. The liquid form is recommended in instances of malabsorption.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Tardive dyskinesia (Off-label indication): 1600 units orally each day</p>
          </list-item>
        </list>
        <p>Pediatric dosing:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vitamin E deficiency
<list list-type="bullet"><list-item><p>Ages 1 month to 12 years: 1 unit/kg/dose by mouth daily.
<list list-type="bullet"><list-item><p>Maximum dosing:
<list list-type="bullet"><list-item><p>Ages 1 month to 3 years of age: 200 units daily</p></list-item><list-item><p>Ages 4 to 8: 300 units daily</p></list-item><list-item><p>Ages 9 to 13: 600 units daily</p></list-item><list-item><p>Ages 14 to 18: 800 units daily</p></list-item></list>
</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Renal and hepatic dose adjustments are not defined.</p>
        <p>Intramuscular vitamin E is not readily available but may be necessary for severe cholestasis or those with genetic disorders, with injections occurring weekly.<xref ref-type="bibr" rid="article-31226.r16">[16]</xref></p>
      </sec>
      <sec id="article-31226.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Common side effects of alpha-tocopherol supplementation include nausea, headache, changes in vision, gastrointestinal upset, risk of hemorrhagic stroke, mild increase in urine creatinine, and necrotizing enterocolitis. There is a potential risk of increased bleeding intraoperatively, as vitamin E is known to inhibit the aggregation of platelets. Yet, it has not been shown in those who are not already on antiplatelet or anticoagulants.<xref ref-type="bibr" rid="article-31226.r19">[19]</xref>&#x000a0;</p>
        <p>Alpha-tocopherol undergoes metabolism in the liver CYP450 enzymes and therefore monitoring for drug interactions if the patient is on medications that inhibit or induce these enzymes is recommended.<xref ref-type="bibr" rid="article-31226.r4">[4]</xref></p>
      </sec>
      <sec id="article-31226.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Vitamin E supplementation is contraindicated in persons with known allergies to the vitamin or components of the formulation.</p>
      </sec>
      <sec id="article-31226.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Deficiency in vitamin E is uncommon, and therefore monitoring of levels is not routinely conducted. However, disorders leading to fat malabsorption can cause deficiency, and consequently, the measurement of serum alpha-tocopherol is warranted.&#x000a0;These disorders include cystic fibrosis, chronic pancreatitis, diseases leading to cholestasis, genetic mutations leading to abetalipoproteinemia, and low levels of alpha-tocopherol transport protein. Levels of alpha-tocopherol less than 0.5 mg/dL are considered a deficiency.<xref ref-type="bibr" rid="article-31226.r20">[20]</xref>&#x000a0;</p>
        <p>The provider must remember that serum alpha-tocopherol depends on serum lipids and proteins. Therefore, in patients with high total lipid levels, the measurement of serum alpha-tocopherol is best estimated by dividing the level by the total lipid. Additionally, since vitamin E and other fat-soluble vitamins require carrier proteins, those with other hypoproteinemic states may have lower measurements of such vitamins.</p>
      </sec>
      <sec id="article-31226.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Hypervitaminosis E is rare and the least toxic of the fat-soluble vitamins. For adults, the upper limits of vitamin E replacement are 1500 to 2200 international units depending on whether the patient is using a natural or synthetic source, respectively. Daily limits for children depend on the child's age, starting at 200 international units at one year of age to 800 international units by 18 years old. Staying well below these levels, however, is recommended for daily supplementation.<xref ref-type="bibr" rid="article-31226.r16">[16]</xref>&#x000a0;</p>
        <p>Studies of high-dose Vitamin E supplementation have been small in number but suggest an associated increase in all-cause mortality. Decreased absorption of other fat-soluble vitamins is known to occur with high serum vitamin E leading to impairment of bone mineralization, coagulopathies, and decreased vitamin A storage.<xref ref-type="bibr" rid="article-31226.r21">[21]</xref><xref ref-type="bibr" rid="article-31226.r12">[12]</xref>&#x000a0;Discontinuation of vitamin E intake and supportive care are recommended in the setting of toxicity.</p>
      </sec>
      <sec id="article-31226.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>As with many supplements, vitamin E supplements are readily available over the counter. It is the responsibility of the interprofessional health care team, including clinicians (MDs, DOs, NPs, PAs), nurses, and pharmacists, to guide preventative health measures and the therapeutic use of vitamin E. All interprofessional team members must communicate across disciplinary lines about all drugs and supplements the patient is taking to operate from the same data and optimize patient care. [Level 5]</p>
        <p>As deficiency is rare, routine supplementation is not a recommended practice, and the patient should be encouraged to eat a balanced diet to obtain the proper alpha-tocopherol levels. If the recommendation is for supplementation, monitoring for common adverse reactions, medication interactions, and risks for bleeding, especially if the patient is taking aspirin or other anticoagulants, should be conducted during the health visit.</p>
      </sec>
      <sec id="article-31226.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31226&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31226">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31226/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31226">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31226.s11">
        <title>References</title>
        <ref id="article-31226.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colombo</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>An update on vitamin E, tocopherol and tocotrienol-perspectives.</article-title>
            <source>Molecules</source>
            <year>2010</year>
            <month>Mar</month>
            <day>24</day>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>2103</fpage>
            <page-range>2103-13</page-range>
            <pub-id pub-id-type="pmid">20428030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hensley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Benaksas</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Bolli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Comp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grammas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hamdheydari</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pye</surname>
                <given-names>QN</given-names>
              </name>
              <name>
                <surname>Stoddard</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Wallis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wechter</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Floyd</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine.</article-title>
            <source>Free Radic Biol Med</source>
            <year>2004</year>
            <month>Jan</month>
            <day>01</day>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-15</page-range>
            <pub-id pub-id-type="pmid">14732286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cirneala</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Lupsan</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Iurciuc</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dimitriu</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Costache</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Petris</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Costache</surname>
                <given-names>II</given-names>
              </name>
            </person-group>
            <article-title>The Effect of Vitamin Supplementation on Subclinical Atherosclerosis in Patients without Manifest Cardiovascular Diseases: Never-ending Hope or Underestimated Effect?</article-title>
            <source>Molecules</source>
            <year>2020</year>
            <month>Apr</month>
            <day>09</day>
            <volume>25</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">32283588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brigelius-Floh&#x000e9;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Salonen</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Neuzil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zingg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Azzi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The European perspective on vitamin E: current knowledge and future research.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>76</volume>
            <issue>4</issue>
            <fpage>703</fpage>
            <page-range>703-16</page-range>
            <pub-id pub-id-type="pmid">12324281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Traber</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>A history of vitamin E.</article-title>
            <source>Ann Nutr Metab</source>
            <year>2012</year>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>207</fpage>
            <page-range>207-12</page-range>
            <pub-id pub-id-type="pmid">23183290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Th&#x000e9;baut</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nemeth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Le Mouha&#x000eb;r</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scheenstra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baumann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Koot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gottrand</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Houwen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Monard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Micheaux</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Habes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jacquemin</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Oral Tocofersolan Corrects or Prevents Vitamin E Deficiency in Children With Chronic Cholestasis.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>610</fpage>
            <page-range>610-615</page-range>
            <pub-id pub-id-type="pmid">27429423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Angulo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petterson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Fat-soluble vitamin levels in patients with primary biliary cirrhosis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>96</volume>
            <issue>9</issue>
            <fpage>2745</fpage>
            <page-range>2745-50</page-range>
            <pub-id pub-id-type="pmid">11569705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Ataxia with Vitamin E Deficiency May Present with Cervical Dystonia.</article-title>
            <source>Tremor Other Hyperkinet Mov (N Y)</source>
            <year>2016</year>
            <volume>6</volume>
            <fpage>374</fpage>
            <pub-id pub-id-type="pmid">27274910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Warrenburg</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>van Gaalen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boesch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burgunder</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>D&#x000fc;rr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giunti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Klockgether</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mariotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pandolfo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riess</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.</article-title>
            <source>Eur J Neurol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>552</fpage>
            <page-range>552-62</page-range>
            <pub-id pub-id-type="pmid">24418350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kayden</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Traber</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans.</article-title>
            <source>J Lipid Res</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-58</page-range>
            <pub-id pub-id-type="pmid">8468520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Donato</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Federico</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ataxia with vitamin E deficiency: update of molecular diagnosis.</article-title>
            <source>Neurol Sci</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>511</fpage>
            <page-range>511-5</page-range>
            <pub-id pub-id-type="pmid">20464573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bjelakovic</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nikolova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gluud</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>9</issue>
            <fpage>e74558</fpage>
            <pub-id pub-id-type="pmid">24040282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Gaziano</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ridker</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Manson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hennekens</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Buring</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.</article-title>
            <source>JAMA</source>
            <year>2005</year>
            <month>Jul</month>
            <day>06</day>
            <volume>294</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-65</page-range>
            <pub-id pub-id-type="pmid">15998891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Darke</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Penney</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Tangen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peisch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tinianow</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Rae</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Kantoff</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Mucci</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>1050</fpage>
            <page-range>1050-1058</page-range>
            <pub-id pub-id-type="pmid">27197287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uchida</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Takaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease.</article-title>
            <source>Nutrients</source>
            <year>2018</year>
            <month>Jul</month>
            <day>27</day>
            <volume>10</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">30060482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartlett</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eperjesi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2005</year>
            <month>May</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>179</fpage>
            <page-range>179-94</page-range>
            <pub-id pub-id-type="pmid">15854063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lawrenson</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jul</month>
            <day>30</day>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>CD000253</fpage>
            <pub-id pub-id-type="pmid">28756617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farina</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Llewellyn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Isaac</surname>
                <given-names>MGEKN</given-names>
              </name>
              <name>
                <surname>Tabet</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vitamin E for Alzheimer's dementia and mild cognitive impairment.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Apr</month>
            <day>18</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD002854</fpage>
            <pub-id pub-id-type="pmid">28418065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pastori</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carnevale</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cangemi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saliola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nocella</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bartimoccia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vicario</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Farcomeni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Violi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pignatelli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy: a retrospective cohort study.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2013</year>
            <month>Oct</month>
            <day>28</day>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>e000364</fpage>
            <pub-id pub-id-type="pmid">24166490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <collab>Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds</collab>
            <source>Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids</source>
            <publisher-name>National Academies Press (US)</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>2000</year>
            <pub-id pub-id-type="pmid">25077263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31226.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Pastor-Barriuso</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dalal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riemersma</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Appel</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Guallar</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.</article-title>
            <source>Ann Intern Med</source>
            <year>2005</year>
            <month>Jan</month>
            <day>04</day>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-46</page-range>
            <pub-id pub-id-type="pmid">15537682</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
